Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of HYR-PB21 for postoperative analgesia after unilateral hallux valgus osteotomy
CTR20253190Phase 3Active
- Sponsor
- Hefei Cosource Pharmaceutical
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HYR-PB21 in postoperative pain, sponsored by Hefei Cosource Pharmaceutical. Started Sep 2025; status: active.
02
Drugs
HYR-PB21
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20253190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253190.